Updated Jul 16, 2026
Moreadith Randall has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $848K.
Randall Moreadith is the Chief Scientific Officer at Serina Therapeutics, Inc., a clinical-stage biotechnology company focused on developing drug candidates for neurological diseases and pain. He has been involved in multiple SEC filings related to the company's operations.
| Role | Chief Scientific Officer |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-24 | SER | Serina Therapeutics, Inc. | S — Open-market sale | 6.5K | $2.86 | $19K |
| 2026-03-24 | SER | Serina Therapeutics, Inc. | M — Option exercise | 6.5K | $0.06 | $390 |
| 2026-03-20 | SER | Serina Therapeutics, Inc. | S — Open-market sale | 39.0K | $2.50 | $98K |
| 2026-03-20 | SER | Serina Therapeutics, Inc. | M — Option exercise | 39.0K | $0.06 | $2K |
| 2026-02-03 | SER | Serina Therapeutics, Inc. | S — Open-market sale | 6.5K | $3.03 | $20K |
| 2026-02-03 | SER | Serina Therapeutics, Inc. | M — Option exercise | 6.5K | $0.06 | $390 |
| 2026-01-29 | SER | Serina Therapeutics, Inc. | S — Open-market sale | 6.5K | $3.57 | $23K |
| 2026-01-29 | SER | Serina Therapeutics, Inc. | M — Option exercise | 6.5K | $0.06 | $390 |
| 2026-01-23 | SER | Serina Therapeutics, Inc. | S — Open-market sale | 2.5K | $2.95 | $7K |
| 2026-01-23 | SER | Serina Therapeutics, Inc. | M — Option exercise | 2.5K | $0.06 | $150 |
| 2026-01-22 | SER | Serina Therapeutics, Inc. | S — Open-market sale | 2.0K | $3.00 | $6K |
| 2026-01-22 | SER | Serina Therapeutics, Inc. | M — Option exercise | 2.0K | $0.06 | $120 |
| 2026-01-22 | SER | Serina Therapeutics, Inc. | S — Open-market sale | 2.0K | $3.07 | $6K |
| 2026-01-22 | SER | Serina Therapeutics, Inc. | M — Option exercise | 2.0K | $0.06 | $120 |
| 2025-12-16 | SER | Serina Therapeutics, Inc. | S — Open-market sale | 1.7K | $3.26 | $6K |
| 2025-12-16 | SER | Serina Therapeutics, Inc. | M — Option exercise | 1.7K | $0.06 | $102 |
| 2025-12-04 | SER | Serina Therapeutics, Inc. | S — Open-market sale | 5.0K | $3.52 | $18K |
| 2025-12-04 | SER | Serina Therapeutics, Inc. | M — Option exercise | 5.0K | $0.06 | $300 |
| 2025-12-04 | SER | Serina Therapeutics, Inc. | S — Open-market sale | 1.5K | $3.91 | $6K |
| 2025-12-04 | SER | Serina Therapeutics, Inc. | M — Option exercise | 1.5K | $0.06 | $90 |
Randall Moreadith is the Chief Scientific Officer at Serina Therapeutics, Inc., a clinical-stage biotechnology company focused on developing drug candidates for neurological diseases and pain. He has been involved in multiple SEC filings related to the company's operations.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 23 open-market sales ($848K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Moreadith Randall profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.